BUSM Research Featured at Society for Neuroscience Annual Meeting

The latest research from the Laboratory of Molecular NeuroTherapeutics of Tsuneya Ikezu, MD, PhD, from the Departments of Pharmacology and Experimental Therapeutics and Neurology, was featured as a “Hot Topic”  for press conference at the recent Society for Neuroscience meeting in Washington, DC.

Ikezu’s latest work entitled “Microglia and exosome-mediated spread of pathogenic tau in Alzheimer’s disease (AD) attempts to further the understanding of Alzheimer’s disease and how brain damage caused by AD spreads from one portion of the brain to the next. According to Ikezu it is now thought that by understanding and eventually preventing this progression one may limit the effects and impact of this devastating disease. Ikezu’s team looked at the role of a specific brain cell known as microglia as a possible “shuttle” for one of the presumed culprit molecules in AD’s tau protein.

Comprising more than 40,000 members, the Society for Neuroscience is the world’s largest organization of scientists and physicians dedicated to nervous system research.